×

Methods of using OSK1 peptide analogs

  • US 7,825,093 B2
  • Filed: 10/25/2007
  • Issued: 11/02/2010
  • Est. Priority Date: 10/25/2006
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of mitigating a relapse of a symptom of multiple sclerosis, comprising administering to a patient, who has previously experienced at least one symptom of multiple sclerosis, an effective amount of an OSK1 peptide analog that comprises the amino acid sequence of SEQ ID NO:

  • 4916, or a pharmaceutically acceptable salt of the OSK1 peptide analog, such that the at least one symptom of multiple sclerosis is mitigated.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×